Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

This seminal finding led to the discovery ... advances in HLA antibody detection have occurred. Solid-phase, multiplex testing platforms have replaced traditional cell-based assays, and have ...

to advance the drug discovery of the variable heavy domain of heavy chain (VHH) antibodies to develop new therapeutic agents. The alliance will leverage EME's humanised VHH screening platform ...

AI for accelerated antibody discovery Traditionally ... the company has its own automation platform to rapidly synthesise and test antibodies in iterations. 2) BigHat Biosciences: Founded in ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

"Our AI-powered pipeline represents a major leap forward for IPA," said Dr. Jennifer Bath, CEO of ImmunoPrecise Antibodies. "By harnessing AI and rethinking drug discovery from the ground up ...

HLA screening assays are used to detect the presence or absence of HLA antibodies and do not typically provide any information on HLA specificity of the detected antibodies. The function of the ...